| Market Capitalization (Millions $) |
53 |
| Shares
Outstanding (Millions) |
26 |
| Employees |
1,278 |
| Revenues (TTM) (Millions $) |
19 |
| Net Income (TTM) (Millions $) |
-21 |
| Cash Flow (TTM) (Millions $) |
6 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Immunoprecise Antibodies Ltd is a biotechnology company that specializes in the discovery and development of novel therapeutic antibodies for the treatment of various diseases. The company utilizes advanced antibody discovery platforms and cutting-edge technologies to generate high-quality antibodies with desirable characteristics, including specificity, affinity, and stability.
Immunoprecise Antibodies offers a range of services, including antibody discovery, development, engineering, and production. They work with pharmaceutical and biotechnology companies, as well as academic institutions, to accelerate the development of innovative antibody-based therapeutics.
The company's state-of-the-art facilities and experienced team of scientists enable them to provide comprehensive solutions for antibody development, from initial target validation to preclinical and clinical development. They also offer a diverse portfolio of proprietary antibody libraries and reagents to meet the specific needs of their clients.
Immunoprecise Antibodies places a strong emphasis on research and innovation, constantly exploring new technologies and approaches to improve their antibody discovery and development processes. This commitment to scientific excellence has established them as a global leader in the field of antibody therapeutics.
Company Address: 3204 - 4464 Markham Street Victoria 0 BC
Company Phone Number: 404-1043 Stock Exchange / Ticker: NASDAQ IPA
|
0.38% 